vs

Side-by-side financial comparison of cbdMD, Inc. (YCBD) and zSpace, Inc. (ZSPC). Click either name above to swap in a different company.

cbdMD, Inc. is the larger business by last-quarter revenue ($5.0M vs $4.8M, roughly 1.0× zSpace, Inc.). cbdMD, Inc. runs the higher net margin — -5.6% vs -150.3%, a 144.7% gap on every dollar of revenue.

cbdMD, Inc. is a U.S.-based consumer wellness company that manufactures and distributes hemp-derived CBD products, including tinctures, topicals, gummies, pet care items, and bath products. All offerings undergo third-party quality testing, and are sold via e-commerce platforms, brick-and-mortar retail stores, and wellness partner channels primarily across the United States.

zSpace, Inc. is an American technology firm based in San Jose, California that delivers virtual and augmented reality experiences in STEM, CTE, and career readiness programs from a computer. zSpace mostly provides AR/VR technology to the education market, allowing teachers and learners to interact with simulated objects in virtual environments.

YCBD vs ZSPC — Head-to-Head

Bigger by revenue
YCBD
YCBD
1.0× larger
YCBD
$5.0M
$4.8M
ZSPC
Higher net margin
YCBD
YCBD
144.7% more per $
YCBD
-5.6%
-150.3%
ZSPC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
YCBD
YCBD
ZSPC
ZSPC
Revenue
$5.0M
$4.8M
Net Profit
$-283.1K
$-7.3M
Gross Margin
59.8%
49.1%
Operating Margin
-5.7%
-116.2%
Net Margin
-5.6%
-150.3%
Revenue YoY
-1.9%
Net Profit YoY
-1975.7%
EPS (diluted)
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
YCBD
YCBD
ZSPC
ZSPC
Q4 25
$5.0M
$4.8M
Q3 25
$4.7M
$8.8M
Q2 25
$4.6M
$7.5M
Q1 25
$4.7M
$6.8M
Q4 24
$5.1M
Q3 24
$4.6M
Q2 24
$5.2M
Q1 24
$4.4M
Net Profit
YCBD
YCBD
ZSPC
ZSPC
Q4 25
$-283.1K
$-7.3M
Q3 25
$-680.0K
$-6.2M
Q2 25
$-895.3K
$-6.1M
Q1 25
$-480.8K
$-5.8M
Q4 24
$15.1K
Q3 24
$-152.8K
Q2 24
$459.7K
Q1 24
$-3.0M
Gross Margin
YCBD
YCBD
ZSPC
ZSPC
Q4 25
59.8%
49.1%
Q3 25
58.8%
51.2%
Q2 25
61.5%
42.6%
Q1 25
62.3%
47.4%
Q4 24
66.5%
Q3 24
53.9%
Q2 24
65.8%
Q1 24
59.0%
Operating Margin
YCBD
YCBD
ZSPC
ZSPC
Q4 25
-5.7%
-116.2%
Q3 25
-14.5%
-54.5%
Q2 25
-19.6%
-84.9%
Q1 25
-10.2%
-79.7%
Q4 24
-1.7%
Q3 24
-6.9%
Q2 24
-7.4%
Q1 24
-35.4%
Net Margin
YCBD
YCBD
ZSPC
ZSPC
Q4 25
-5.6%
-150.3%
Q3 25
-14.4%
-70.2%
Q2 25
-19.4%
-81.8%
Q1 25
-10.1%
-86.3%
Q4 24
0.3%
Q3 24
-3.4%
Q2 24
8.9%
Q1 24
-68.8%
EPS (diluted)
YCBD
YCBD
ZSPC
ZSPC
Q4 25
$-0.22
Q3 25
$-0.26
Q2 25
$-0.27
Q1 25
$-0.26
Q4 24
Q3 24
Q2 24
$-0.15
Q1 24
$-1.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
YCBD
YCBD
ZSPC
ZSPC
Cash + ST InvestmentsLiquidity on hand
$3.4M
Total DebtLower is stronger
$17.7M
Stockholders' EquityBook value
$9.0M
$-22.5M
Total Assets
$11.8M
$7.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
YCBD
YCBD
ZSPC
ZSPC
Q4 25
$3.4M
Q3 25
$2.3M
Q2 25
$1.1M
Q1 25
$1.8M
Q4 24
$2.0M
Q3 24
$2.5M
Q2 24
$2.4M
Q1 24
$2.1M
Total Debt
YCBD
YCBD
ZSPC
ZSPC
Q4 25
$17.7M
Q3 25
$18.7M
Q2 25
$18.1M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
YCBD
YCBD
ZSPC
ZSPC
Q4 25
$9.0M
$-22.5M
Q3 25
$7.2M
$-19.7M
Q2 25
$6.1M
$-22.3M
Q1 25
$665.8K
$-19.6M
Q4 24
$1.8M
Q3 24
$2.0M
Q2 24
$3.0M
Q1 24
$3.1M
Total Assets
YCBD
YCBD
ZSPC
ZSPC
Q4 25
$11.8M
$7.6M
Q3 25
$10.4M
$13.5M
Q2 25
$9.9M
$12.1M
Q1 25
$10.9M
$9.8M
Q4 24
$11.5M
Q3 24
$10.6M
Q2 24
$13.8M
Q1 24
$14.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
YCBD
YCBD
ZSPC
ZSPC
Operating Cash FlowLast quarter
$-812.5K
$-3.9M
Free Cash FlowOCF − Capex
$-977.3K
FCF MarginFCF / Revenue
-19.5%
Capex IntensityCapex / Revenue
3.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-2.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
YCBD
YCBD
ZSPC
ZSPC
Q4 25
$-812.5K
$-3.9M
Q3 25
$-240.7K
$-2.5M
Q2 25
$-704.2K
$-6.9M
Q1 25
$-189.5K
$-4.6M
Q4 24
$-317.9K
Q3 24
$167.4K
Q2 24
$289.8K
Q1 24
$-704.1K
Free Cash Flow
YCBD
YCBD
ZSPC
ZSPC
Q4 25
$-977.3K
Q3 25
$-243.6K
Q2 25
$-705.7K
Q1 25
$-205.0K
Q4 24
$-482.3K
Q3 24
$157.4K
Q2 24
Q1 24
$-708.7K
FCF Margin
YCBD
YCBD
ZSPC
ZSPC
Q4 25
-19.5%
Q3 25
-5.2%
Q2 25
-15.3%
Q1 25
-4.3%
Q4 24
-9.4%
Q3 24
3.5%
Q2 24
Q1 24
-16.2%
Capex Intensity
YCBD
YCBD
ZSPC
ZSPC
Q4 25
3.3%
Q3 25
0.1%
Q2 25
0.0%
Q1 25
0.3%
Q4 24
3.2%
Q3 24
0.2%
Q2 24
0.0%
Q1 24
0.1%
Cash Conversion
YCBD
YCBD
ZSPC
ZSPC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-21.06×
Q3 24
Q2 24
0.63×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

YCBD
YCBD

Sales Channel Directly To Consumer$3.6M72%
Sales Channel Through Intermediary$1.4M28%

ZSPC
ZSPC

Transferred At Point In Time$4.6M94%
Other$287.0K6%

Related Comparisons